目次

Executive Summary
Market overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Therapy type
Market segments
Comparison by Therapy type
First line of treatment - Market size and forecast 2020-2025
Second line of treatment - Market size and forecast 2020-2025
Market opportunity by Therapy type

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Amgen Inc.
AMYRA Biotech AG
BioLineRx Ltd.
Bristol-Myers Squibb Co.
Calypso Biotech
GlaxoSmithKline Plc
Immunogenics LLC
Johnson and Johnson Inc.
Sanofi SA
Takeda Pharmaceutical Co. Ltd.

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Therapy type - Market share 2020-2025 (%)
22: Comparison by Therapy type
23: First line of treatment - Market size and forecast 2020-2025 ($ million)
24: First line of treatment - Year-over-year growth 2020-2025 (%)
25: Second line of treatment - Market size and forecast 2020-2025 ($ million)
26: Second line of treatment - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Therapy type
28: Customer landscape
29: Market share By Geographical Landscape 2020-2025 (%)
30: Geographic comparison
31: North America - Market size and forecast 2020-2025 ($ million)
32: North America - Year-over-year growth 2020-2025 (%)
33: Europe - Market size and forecast 2020-2025 ($ million)
34: Europe - Year-over-year growth 2020-2025 (%)
35: Asia - Market size and forecast 2020-2025 ($ million)
36: Asia - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity By Geographical Landscape ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Amgen Inc. - Overview
48: Amgen Inc. - Business segments
49: Amgen Inc. - Key offerings
50: Amgen Inc. - Key customers
51: Amgen Inc. - Segment focus
52: AMYRA Biotech AG - Overview
53: AMYRA Biotech AG - Product and service
54: AMYRA Biotech AG - Key offerings
55: AMYRA Biotech AG - Key customers
56: AMYRA Biotech AG - Segment focus
57: BioLineRx Ltd. - Overview
58: BioLineRx Ltd. - Product and service
59: BioLineRx Ltd. - Key offerings
60: BioLineRx Ltd. - Key customers
61: BioLineRx Ltd. - Segment focus
62: Bristol-Myers Squibb Co. - Overview
63: Bristol-Myers Squibb Co. - Product and service
64: Bristol-Myers Squibb Co. - Key offerings
65: Bristol-Myers Squibb Co. - Key customers
66: Bristol-Myers Squibb Co. - Segment focus
67: Calypso Biotech - Overview
68: Calypso Biotech - Product and service
69: Calypso Biotech - Key offerings
70: Calypso Biotech - Key customers
71: Calypso Biotech - Segment focus
72: GlaxoSmithKline Plc - Overview
73: GlaxoSmithKline Plc - Business segments
74: GlaxoSmithKline Plc - Key offerings
75: GlaxoSmithKline Plc - Key customers
76: GlaxoSmithKline Plc - Segment focus
77: Immunogenics LLC - Overview
78: Immunogenics LLC - Product and service
79: Immunogenics LLC - Key offerings
80: Immunogenics LLC - Key customers
81: Immunogenics LLC - Segment focus
82: Johnson and Johnson Inc. - Overview
83: Johnson and Johnson Inc. - Business segments
84: Johnson and Johnson Inc. - Key offerings
85: Johnson and Johnson Inc. - Key customers
86: Johnson and Johnson Inc. - Segment focus
87: Sanofi SA - Overview
88: Sanofi SA - Business segments
89: Sanofi SA - Key offerings
90: Sanofi SA - Key customers
91: Sanofi SA - Segment focus
92: Takeda Pharmaceutical Co. Ltd. - Overview
93: Takeda Pharmaceutical Co. Ltd. - Product and service
94: Takeda Pharmaceutical Co. Ltd. - Key offerings
95: Takeda Pharmaceutical Co. Ltd. - Key customers
96: Takeda Pharmaceutical Co. Ltd. - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations